EUVIMEDEUVIMED entdecken
Open Access

Bayesian Adaptive Enrichment Design for Continuous Biomarkers

Yue Tu, Yusha Liu, Wendy J Mack, Lindsay A Renfro iD

Statistics in Medicine · 2025

DOI: 10.1002/sim.70262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2025. Verfasst von Yue Tu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Biomarkers, Randomized Controlled Trials as Topic, Research Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the advent of precision medicine and targeted therapies in cancer, new challenges in the statistical design of clinical trials have naturally emerged. Most randomized clinical trial designs incorporating predictive biomarkers (those associated with treatment efficacy) assume biomarkers are dichotomous, or dichotomize naturally continuous biomarkers upfront, or find cut points mid‐way through the trial to classify patients as biomarker‐positive or biomarker‐negative. However, these practices ignore or discard information about continuous and possible nonlinear or non‐monotone prognostic or predictive effects. In this article, we propose a novel adaptive enrichment trial design to handle continuous biomarkers with any effect shape, including Bayesian marker‐adaptive randomization. We demonstrate that this design can correctly make marker‐specific trial decisions with high efficiency, resulting in improved performance and patient‐centered decisions compared to adaptive cut‐point selection approaches without adaptive randomization that further ignore or oversimplify true underlying marker relationships.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersRandomized Controlled Trials as TopicResearch DesignHumansBayes TheoremPrecision MedicineComputer SimulationNeoplasmsModels, StatisticalBiomarkers, Tumor

Stichwörter der Autor:innen

Bayesian adaptive designadaptive enrichment designadaptive randomizationbiomarker‐driven designclinical trialprecision medicine

Substanzen

BiomarkersBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA.
  • Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Children's Oncology Group, Monrovia, California, USA.

ORCID-Profile: Lindsay A Renfro

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Tu, Y., Liu, Y., Mack, W. J., & Renfro, L. A. (2025). Bayesian Adaptive Enrichment Design for Continuous Biomarkers. Statistics in Medicine. https://doi.org/10.1002/sim.70262

Vancouver

Tu Y, Liu Y, Mack WJ, Renfro LA. Bayesian Adaptive Enrichment Design for Continuous Biomarkers. Statistics in Medicine. 2025. doi:10.1002/sim.70262

BibTeX
@article{Tu2025,
  author = {Tu, Yue and Liu, Yusha and Mack, Wendy J and Renfro, Lindsay A},
  title = {Bayesian Adaptive Enrichment Design for Continuous Biomarkers},
  journal = {Statistics in Medicine},
  year = {2025},
  doi = {10.1002/sim.70262}
}
Kostenlos starten →